TransMedics Overview

  • Founded
  • 1998
Founded
  • Status
  • Public
  • Employees
  • 109
Employees
  • Stock Symbol
  • TMDX
Stock Symbol
  • Share Price
  • $12.39
  • (As of Thursday Closing)

TransMedics General Information

Description

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes the technology to replicate near-physiologic conditions for donor organs outside of the human body.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Stock Exchange
NAS
Primary Office
  • 200 Minuteman Road
  • Suite 302
  • Andover, MA 01810
  • United States
+1 (978) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TransMedics Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$12.39 $12.65 $10.10 - $20.99 $336M 27.2M 179K -$1.60

TransMedics Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 447,553 348,072
Revenue 24,183 23,604 13,017 7,685
EBITDA (29,147) (27,932) (20,226) (19,089)
Net Income (34,806) (33,547) (23,756) (20,823)
Total Assets 163,137 105,299 42,157 37,001
Total Debt 34,395 34,146 33,670 8,652
Public Fundamental Data provided by Morningstar, Inc. disclaimer

TransMedics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore TransMedics‘s full profile, request access.

Request a free trial

TransMedics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore TransMedics‘s full profile, request access.

Request a free trial

TransMedics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-sta
Surgical Devices
Andover, MA
109 As of 2019
00000
0000 0000-00-00
00000000 00000

00000000

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatu
00000000 0000000
St. Paul, MN
000 As of 0000
00000
00000000000 00000

00000

n reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occae
0000000 00000000
Göteborg, Sweden
00 As of 0000
0000
000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TransMedics Competitors (23)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cardiovascular Systems Formerly VC-backed St. Paul, MN 000 00000 00000000000 00000
00000 Corporation Göteborg, Sweden 00 0000 000000000 0000
0000000 Venture Capital-Backed Clichy, France 00 000.00 0000000000 000.00
00000000 000000000 Venture Capital-Backed Emeryville, CA 00 000.00 000000000 - 000.00
00000000 000000000 Venture Capital-Backed Hilden, Germany 0 000.00 0000000000 0 000.00
You’re viewing 5 of 23 competitors. Get the full list »

TransMedics Executive Team (16)

Name Title Board Seat Contact Info
Waleed Hassanein MD Chief Executive Officer & Board Member
Stephen Gordon Chief Financial Officer, Finance & Secretary, Administration
Tamer Khayal MD Executive
John Carey Vice President
John Sullivan Vice President
You’re viewing 5 of 16 executive team members. Get the full list »

TransMedics Board Members (14)

Name Representing Role Since
Adam Grosser Self Board Member 000 0000
David Abrams Abrams Capital Management Board Member 000 0000
Earl Collier JD Self Board Member 000 0000
Edward Basile JD Self Board Member 000 0000
Edwin Kania Jr. Flagship Pioneering Board Member 000 0000
You’re viewing 5 of 14 board members. Get the full list »

TransMedics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TransMedics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore TransMedics‘s full profile, request access.

Request a free trial